Common questions about Gaviscon Nourrisson (FAQ)
Q: Is Gaviscon Nourrisson the same as infant formula thickeners?
Regulatory documents caution that the product must not be used together with other feed thickening agents or infant milk preparations that already contain a thickening agent. This combination is cautioned against in regulatory documents to mitigate the risk of excessive thickening of the stomach contents.
Q: How long can a baby stay on Gaviscon Nourrisson?
Treatment should continue until the infant’s symptoms resolve. Official guidance states that if symptoms persist or worsen after mathbf7 days of treatment, a medical review is recommended according to regulatory guidance.
Q: Does Gaviscon Nourrisson contain aluminum?
The active ingredients listed in regulatory documents are sodium alginate and magnesium alginate. Aluminum compounds are not listed as active ingredients or excipients in the product composition.
Q: Does Gaviscon Nourrisson interact with iron supplements?
Yes, official guidance states that a mathbf2-hour time interval should be considered between giving Gaviscon Nourrisson and the administration of most other oral medicines, including iron salts (a type of iron supplement). This separation is required as the alginate preparation may reduce the absorption and bioavailability of co-administered oral medicines.
Q: What is the official European regulatory classification for Gaviscon Nourrisson?
In some regulatory jurisdictions, the product is officially designated as a Pharmacy Only medicine. This means it is a non-prescription product, but its supply is restricted to a pharmacy setting.
Q: Are there any long-term safety concerns described for Gaviscon Nourrisson?
The product’s safety profile is based on its physical action within the stomach. Known documented adverse effects are generally rare, but include constipation, diarrhea, and very rarely, intestinal obstruction. Due to the mathbfsodium content, the product is officially contraindicated for use in infants with known or suspected renal impairment (kidney issues).
Q: What is the maximum duration of treatment mentioned in official product information?
Official guidance indicates that treatment should continue until symptoms resolve. A medical review is recommended in official product information if symptoms persist or worsen after mathbf7 days.
Q: Can Gaviscon Nourrisson be used in combination with antacids?
Gaviscon Nourrisson is classified as a raft-forming agent and a local antacid itself. While combining it with other antacids is not explicitly forbidden in regulatory documents, the use of all other oral medicines requires a mathbf2-hour separation due to potential absorption interference.
Q: Does Gaviscon Nourrisson have a bitter taste that babies might dislike?
Official regulatory documents for the liquid form of Gaviscon Nourrisson describe the product as having a banana flavor to improve palatability for infants.
Q: Can Gaviscon Nourrisson be used for simple spit-up that isn't true reflux?
Yes, the product is officially indicated for use in managing both gastric regurgitation (simple spit-up) and gastro-oesophageal reflux in infants and young children.
Q: How quickly can I expect to see an effect after giving Gaviscon Nourrisson?
Due to its rapid physical action, which involves forming a gel barrier on the stomach contents, the medicine is described in some guidance as starting to act or provide relief within about mathbf30 minutes after administration.
Q: Is it normal if my baby seems a little more constipated while using Gaviscon Nourrisson?
Regulatory documents list constipation as a reported adverse reaction associated with the use of this product. If the constipation is significant or sustained, regulatory documents recommend that a medical review be sought.
Q: What age range is Gaviscon Nourrisson specifically intended for?
The medicine is intended for infants and young children. However, official information states that it is not to be used in infants under one year of age or in premature infants mathbfexcept under medical supervision, due to the need for careful dosing and monitoring in this age group.
Q: Can Gaviscon Nourrisson be mixed into water or juice instead of formula or milk?
The powder formulation is designed to be mixed with either formula or cooled boiled water for breastfed or weaned infants. The liquid suspension must be administered as is and should not be mixed with milk or food.
Q: Is there a maximum number of times a baby can receive Gaviscon Nourrisson in a 24-hour period?
For the powder form, the total daily dose should not exceed mathbf6 administrations in a mathbf24-hour period. For the liquid suspension, dosing is generally recommended after each meal or feed.
Q: What if my baby accidentally takes a slightly larger amount than intended?
Regulatory documents indicate that in the event of an overdosage, the patient may experience abdominal discomfort and abdominal distension (bloating). Treatment in this case is symptomatic.
Q: Are there specific food types that might interact with Gaviscon Nourrisson?
Official documents contain a strict warning that the medicine must not be used with infant milk preparations or products that already contain a thickening agent to avoid the risk of over-thickening stomach contents.
Q: Can Gaviscon Nourrisson cause diarrhea?
Regulatory documents list diarrhea as an adverse reaction that has been reported with the use of the product.
Q: Are there different flavors of Gaviscon Nourrisson?
Official regulatory documents for the liquid suspension form of Gaviscon Nourrisson describe the product as having a banana flavor.
Q: Does Gaviscon Nourrisson contain gluten or common allergens?
The powder formulation generally does not contain sugar or gluten. The liquid suspension contains excipients ( methyl parahydroxybenzoate and propyl parahydroxybenzoate) which, in some people, may cause allergic reactions.
Q: Is Gaviscon Nourrisson generally safe to use alongside probiotic drops?
Probiotic drops are considered an orally administered medicine or supplement. Therefore, regulatory guidance states that a mathbf2-hour time interval should be considered between giving Gaviscon and the probiotic drops to mitigate the potential for reduced absorption and bioavailability of the co-administered probiotic.
Q: Does Gaviscon Nourrisson affect the absorption of nutrients from milk or formula?
Regulatory documents focus on the potential to reduce the absorption and bioavailability of co-administered medicines (such as iron salts). Regulatory documents do not specifically list effects on the general absorption of nutrients from milk or formula, though the product’s mode of action is physical and operates within the gastrointestinal tract.
Q: Can Gaviscon Nourrisson be administered to a premature baby?
The patient information leaflet states that the product is not to be used in premature infants mathbfexcept under medical supervision due to the need for careful monitoring in this vulnerable population.
Q: What should I do if my baby shows signs of a possible allergic reaction?
Hypersensitivity reactions, including rash, itching, and in very rare cases, serious systemic reactions like anaphylaxis, are documented as possible. If symptoms are observed, official guidance advises that medical attention should be sought.
Q: How is the medicine stored before it is opened?
The medicine must be kept out of the sight and out of the reach of children and should not be stored above mathbf25 C (or mathbf30 C depending on the specific formulation). This applies to the unopened product.
Q: Are there any research studies about Gaviscon Nourrisson that I can read about?
Official information references research that has focused on short-term randomized controlled trials to examine changes in regurgitation and reflux symptoms. Studies have also utilized specialized monitoring tools such as pH-metry and Multichannel Intraluminal Impedance to track physiological activity.
Q: Can Gaviscon Nourrisson cause increased gas or bloating?
Yes, regulatory documents list flatulence and abdominal distension as adverse reactions that have been reported with the use of the product. Abdominal distension is often referred to as bloating.
Q: Is it considered safe to use Gaviscon Nourrisson with certain types of anti-reflux formula?
Official documentation strictly states the product must not be used simultaneously with any infant milk preparation that already contains a thickening agent to avoid the risk of excessive thickening.
Q: How do doctors monitor a baby's progress while on Gaviscon Nourrisson?
Regulatory documents recommend a medical review if symptoms persist or worsen after mathbf7 days. Monitoring methods used in clinical research include specialized tools such as pH-metry and Multichannel Intraluminal Impedance to track the frequency and nature of reflux episodes.
Q: Does Gaviscon Nourrisson contain sodium?
Yes, regulatory documents state the product mathbfcontains mathbfsodium. For example, the powder form contains approximately mathbf23.9 mg mathbfsodium per sachet, which must be considered for infants with known or suspected renal impairment or those on a controlled low-salt diet.
Q: Is there a concern about the long-term impact on a baby's kidney function?
The product is officially contraindicated in infants with known or suspected impairment of renal function (kidney issues). This is a critical safety measure due to the sodium content, which increases the potential for abnormally high blood sodium levels (hypernatraemia) in these infants.
Q: If the baby misses a dose, is there guidance on what to do?
Guidance for parents suggests that if a dose is missed, it can be given up to an hour after the meal, provided this administration is then separated by at least mathbf2 hours before the next scheduled dose.
Q: Can Gaviscon Nourrisson interact with cough or cold remedies for babies?
Regulatory documents require a mathbf2-hour time interval between giving Gaviscon and the administration of most other orally administered medicines, which would include many common cough and cold remedies, to prevent reduced absorption of the co-administered medicine.
Q: Does Gaviscon Nourrisson contain sugar or artificial sweeteners?
The powder formulation of the medicine mathbfdoes mathbfnot mathbfcontain mathbfsugar. However, the liquid suspension contains Saccharin sodium as an excipient (a type of artificial sweetener).
Q: Is Gaviscon Nourrisson licensed for use in newborns?
Official information states that the product is not to be used in infants under one year of age mathbfexcept under medical supervision. This restriction includes the newborn period.
